NL-OMON30917尚未招募不适用
Contrast Enhanced Ultrasound imaging to support prostate cancer brachytherapy treatment and follow up after treatment - contrast enhanced ultrasound of prostate cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •Biopsy proven prostate cancer, treatment with brachytherapy
排除标准
- •severe cardiac problems, severe hypertension
研究者
相似试验
招募中
不适用
Contrast enhanced ultrasound imaging to support prostate cancer brachytherapy treatment and follow up after treatment.Prostate and cancer.NL-OMON22373Academic Medical Centre Amsterdam, department of urology and department of radiotherapy10
进行中(未招募)
不适用
Contrast enhanced ultrasonography effectiveness in early evaluating of the response to the Sunitinib in the patients with advanced GIST. A pilot study - NDGastrointestinal stromal tumor (GIST)MedDRA version: 9.1Level: LLTClassification code 10061174Term: Gastrointestinal neoplasmEUCTR2007-001928-12-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
进行中(未招募)
1 期
Prospective ultrasound based study of lymphatic vessels using ultrasound contrast agentMedDRA version: 20.0Level: LLTClassification code 10025233Term: LymphedemaSystem Organ Class: 100000004866MedDRA version: 20.0Level: LLTClassification code 10054561Term: Post-mastectomy lymphedema syndromeSystem Organ Class: 100000004863MedDRA version: 20.0Level: LLTClassification code 10036389Term: Postmastectomy lymphedema syndromeSystem Organ Class: 100000004863EUCTR2018-004389-33-FIOlli Lahtinen160
招募中
不适用
Contrast-enhanced ultrasound (CEUS) for assessment of perfusion patterns of musculoskeletal tumorsD48.9Neoplasm of uncertain or unknown behaviour, unspecifiedDRKS00028080Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie300
进行中(未招募)
1 期
Study of placental vascularization using contrast ultrasoundFetal growth restrictionMedDRA version: 20.0Level: PTClassification code: 10070531Term: Foetal growth restriction Class: 100000004868CTIS2023-506936-34-00CHRU De Nancy30
